BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 4342370)

  • 1. [Indications for splenectomy in the anemic forms of myelofibrosis with myeloid metaplasia of the spleen].
    Dechavanne M; Viala JJ; Barbier Y; Revol L
    Sem Hop; 1972 Apr; 48(17):1187-92. PubMed ID: 4342370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioisotope study of erythropoiesis and hemolysis in myelofibrosis with myeloid metaplasia of the spleen. Its value in splenectomy indications].
    Viala JJ; Dechavanne M; Barbier Y
    Lyon Med; 1972 Oct; 228(15):237-44. PubMed ID: 4639048
    [No Abstract]   [Full Text] [Related]  

  • 3. Splenectomy for agnogenic myeloid metaplasia.
    Gomes MR; Silverstein MN; Remine WH
    Surg Gynecol Obstet; 1967 Jul; 125(1):106-8. PubMed ID: 6026679
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrokinetic studies as a guide to the value of splenectomy in primary myeloid metaplasia.
    Milner GR; Geary CG; Wadsworth LD; Doss A
    Br J Haematol; 1973 Oct; 25(4):467-84. PubMed ID: 4752714
    [No Abstract]   [Full Text] [Related]  

  • 5. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [THE KINETICS OF ERYTHROCYTES IN PATIENTS WITH SPLENOMEGALY].
    KUHN W; PRIBILLA W; OETTGEN HF
    Sangre (Barc); 1964; 17():225-30. PubMed ID: 14218352
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of splenic function by means of radioisotope labelled red cells.
    Szur L; Marsh GW; Pettit JE
    Br J Haematol; 1972 Sep; 23():Suppl:183-99. PubMed ID: 4567190
    [No Abstract]   [Full Text] [Related]  

  • 8. [The determination of the site of erythrocyte destruction in hemolytic diseases with the aid of radioisotopes].
    Kuba J; CĂ­hal K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(2):197-208. PubMed ID: 4168344
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical aspects of erythrocyte kinetics in hematologic disorders].
    Honetz N
    Wien Z Inn Med; 1972; 53(2):58-85. PubMed ID: 4504755
    [No Abstract]   [Full Text] [Related]  

  • 10. [The evaluation of hemocatheresis by means of erythrocytes labeled with Cr51 as a test for selection of hemolytic anemia patients to undergo splenectomy].
    Spinelli Ressi F
    Haematol Lat; 1967; 10(4):381-90. PubMed ID: 5593507
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of splenectomy in hemolytic syndromes on the basis of clinical, hematologic and isotope indications.
    Rudowski W; Pawelski S; Konopka L; Kwietniak K; Zdiechowska H; Rechowicz K
    Pol Med J; 1968; 7(3):661-70. PubMed ID: 5669708
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with splenectomy in hematologic diseases].
    Mappes G; Fischer J
    Dtsch Med Wochenschr; 1969 Mar; 94(12):584-9. PubMed ID: 4887591
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypersplenism. What it is and what not].
    Fischer J
    Internist (Berl); 1971 Apr; 12(4):176-86. PubMed ID: 4928640
    [No Abstract]   [Full Text] [Related]  

  • 16. [ERYTHROKINETICS IN OSTEOMYELOFIBROSIS (STUDIES OF THE PRODUCTION AND DESTRUCTION OF ERYTHROCYTES WITH CR 51 FE 59)].
    OETTGEN HF; PRIBILLA W
    Klin Wochenschr; 1964 May; 42():483-90. PubMed ID: 14231205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of erythrocyte kinetics in idiopathic treatment-resistant anemia using iron 59 and chromium 51].
    Frick PG; Brunner HE
    Nucl Med (Stuttg); 1963; 2():Suppl 1:129-34. PubMed ID: 5900103
    [No Abstract]   [Full Text] [Related]  

  • 18. Life-span and organ sequestration of the red cells in pyruvate kinase deficiency.
    Nathan DG; Oski FA; Miller DR; Gardner FH
    N Engl J Med; 1968 Jan; 278(2):73-81. PubMed ID: 5634483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of erythrokinetics with chromium 51 and iron 59 in osteomyelofibrosis].
    Brunner HE; Frick PG
    Nucl Med (Stuttg); 1963; 2():Suppl 1:135-40. PubMed ID: 5900104
    [No Abstract]   [Full Text] [Related]  

  • 20. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.